NCT03935074View on ClinicalTrials.gov

Superselective Intra-arterial Chemotherapy Treatment for Retinoblastoma- 5 Year Results From Turkey

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

August 30, 2016

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Retinoblastoma
Interventions
DRUG

intra-arterial administration of melphalan

Trial Locations (1)

34098

Istanbul University Cerrahpasa School of Medicine Ophthalmology Department, Istanbul

All Listed Sponsors
lead

Istanbul University - Cerrahpasa

OTHER

NCT03935074 - Superselective Intra-arterial Chemotherapy Treatment for Retinoblastoma- 5 Year Results From Turkey | Biotech Hunter | Biotech Hunter